Nvelop Therapeutics
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- $25M
Investors
- 6
About Nvelop Therapeutics
Founded in 2022 by Keith Joung and David Liu, and based in Massachusetts, US, Nvelop Therapeutics operates as a biotechnology research company that develops genetic medicines to treat patients with previously undruggable diseases., to form nChroma Bio. Nvelop Therapeutics focuses on advancing genetic medicine through its delivery platforms, specifically DLVR-X and DLVR-M. These platforms utilize modular, non-viral vehicles engineered for tissue-specific delivery and in vivo editing, addressing critical limitations in current gene therapy delivery technologies. DLVR-X is designed to deliver diverse therapeutic cargoes, including transiently expressed ribonucleoproteins, while minimizing off-target effects. In contrast, DLVR-M emphasizes a fully humanized architecture to enhance targeting profiles and reduce immunogenicity. The geographical markets for Nvelop's product offerings include North America, Europe, and select regions in Asia, targeting research institutions, biotechnology companies, and pharmaceutical manufacturers.
Who invested in Nvelop Therapeutics
6 investors across 1 round
See all investors in Nvelop Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 21, 2022
Amount
$25M
Investors
Questions about Nvelop Therapeutics
Who invested in Nvelop Therapeutics?
Nvelop Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nvelop Therapeutics raised?
Nvelop Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nvelop Therapeutics last raise money?
Nvelop Therapeutics's most recent round on record is a Seed, in Jul 2022.
What does Nvelop Therapeutics do?
Founded in 2022 by Keith Joung and David Liu, and based in Massachusetts, US, Nvelop Therapeutics operates as a biotechnology research company that develops genetic medicines to treat patients with previously undruggable diseases.
Where is Nvelop Therapeutics headquartered?
Nvelop Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Nvelop Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nvelop Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Nvelop Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.